Technology
Health
Pharmaceutical

EyePoint Pharmaceuticals

$1.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.68%) As of 12:00 PM EDT today
-$0.01 (-0.68%) Today

Why Robinhood?

You can buy or sell EYPT and other stocks, options, ETFs, and crypto commission-free!

About EYPT

EyePoint Pharmaceuticals, Inc. Common Stock, also called EyePoint Pharmaceuticals, is a biopharmaceutical company. Read More It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

Employees
44
Headquarters
Watertown, Massachusetts
Founded
1987
Market Cap
140.46M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
283.90K
High Today
$1.53
Low Today
$1.45
Open Price
$1.46
Volume
86.10K
52 Week High
$3.94
52 Week Low
$1.24

Collections

Technology
Health
Pharmaceutical
Biopharmaceutical
US
North America
Female CEOs

EYPT Earnings

-$0.91
-$0.64
-$0.38
-$0.11
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
Expected Aug 7, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.